Functional medicine in China

A real clinical philosophy, a genuine hospital department in China, and the label most often stuck on things that have never been tested. Here is how a 1+X programme is actually assembled, what goes into a functional infusion, and which parts of it have evidence behind them.

The short answer

Functional medicine organises treatment around mechanism instead of diagnosis: it asks which upstream systems are drifting — gut barrier, liver clearance, micronutrient status, inflammatory load, metabolic and hormonal signalling — and intervenes there, usually before any disease has a name. In China it is more institutional than the Western version. Several large private hospital groups run it as a named department inside the hospital, staffed by licensed physicians, working from the same panel and imaging that the screening produced. In the Boao Lecheng pilot zone it sits on the non-cell side of the programme menu with therapeutic plasma exchange, the mitochondrial and NAD+ protocols, hyperbaric oxygen and whole-body immune hyperthermia.

The house shorthand for it here is 1+X, and functional infusion — an intravenous course aimed at a named system rather than a diagnosed disease — is the part of the “1” most guests actually meet. Two things need saying at the start. The structure is coherent and, inside a hospital, it is safer than the same idea sold from a storefront. And the evidence behind individual items on the catalogue ranges from unambiguous to absent, with the strongest predictor being whether a measurement came first. This page is about telling those apart.

Where functional medicine sits next to clinical medicine

The distinction the Chinese groups draw is the one worth borrowing. Clinical medicine, in their framing, is waiting medicine: it is superbly good at naming and treating a disease once the disease exists, and it has almost nothing to offer the ten or twenty years before that. Functional medicine claims that window. It is not an alternative to clinical care and the good departments are emphatic about that — a nodule, a stenosis, a malignancy or a decompensating organ goes to the specialist, today, and no amount of nutritional support substitutes for a stent.

What it offers instead is a different unit of analysis. A diabetic does not die of a blood glucose number; they die of the vascular, renal, ocular and microcirculatory consequences that accumulate around it, and a system that only treats the number is treating the least dangerous part. So functional medicine works on the network: the same guest's lipids, homocysteine, insulin resistance, liver enzymes, micronutrients, gut permeability and sleep are treated as one object rather than as seven appointments.

This is a philosophy of care, not a body of evidence. Adopting the framing does not license any particular intervention inside it, and the honest departments know the difference. The sections below separate the structure from the proof on purpose.

The five-stage model, and where the infusion arrives

The clinical logic these programmes run on sets out five stages between health and disease, and it is genuinely useful as a map even where individual claims on it are unproven:

Two things follow from the table. The infusion is not positioned as a wellness top-up; it is positioned at the point where tissue and organ function have measurably begun to drift but a disease has not yet been named — which is a defensible place to put an intervention and also the hardest place to prove one works, because the endpoint you would need is decades away. And the fifth row is an admission: once there is a disease, the functional programme hands over. A department that will not say that out loud is not one to buy from.

What “1+X” actually names

It is a menu structure, not a medical term. Read as a map of a catalogue it is clarifying, because it tells you where any given item sits and therefore what questions it has to answer.

The catalogue underneath that structure is then sorted by intent rather than by organ, in a sequence the groups write as clear, balance, supplement, reverse, treat: remove the excess, correct the deficit, restore the balance, address the ageing, treat the established disease. It maps onto a treatment tempo too — urgent clinical risk first, then the fast adjustment the infusion is for, then the slow work of oral nutrition, devices and traditional medicine, then the management year. As a scheduling logic it is sound. As a claim it is unproven, and the catalogue's own language about results is house language, not trial data.

Functional infusion: what is actually in the line

Mechanically there is no mystery and no proprietary device. It is a peripheral cannula, a bag whose contents the prescribing physician sets from your results, one to a few hours in a day-treatment chair, and observation through the session. A course in one partner hospital's own programme document runs a single infusion on each of two consecutive days at roughly two and a half hours per session, with an oral supplement combination continuing for about three months afterwards and device sessions layered alongside — the infusion is the short, fast part of a long, slow programme rather than the programme itself.

What goes in the bag is the entire question, and it varies by indication, by physician and by panel. Across these catalogues the recurring targets are liver clearance and detoxification support, gut mucosal repair, metabolic correction, micronutrient repletion, mitochondrial substrate, and blood-optimisation work that shades into the apheresis protocols covered on the plasma exchange page. A good department will tell you the constituents, the dose and the measurement that produced them before you sit down. If the answer is a brand name and a promise, you have learnt what you needed to know.

What the evidence does and does not support

This is the section most pages in this category do not have, so here is the split as plainly as it can be put.

The pattern is not subtle. Every item that survives scrutiny is one where a measurement came first and a re-measurement is planned. Every item that does not is one sold on mechanism alone. That single test will serve you better than any catalogue.

How a house catalogue differs from a guideline

These programmes are documented thoroughly, and it is worth being precise about what that documentation is. A hospital group's programme manual lists its items by system — cardiovascular and cerebrovascular, metabolic, immune, endocrine and reproductive, neurological, respiratory, digestive, skeletal, haematological, and an energy category — and attaches to each a stated core advantage and a course structure. Some of them also run a formal outcome-evaluation process: a named set of indicators agreed with the guest before the course starts, four dimensions of assessment (laboratory values, imaging, symptoms and how the guest actually feels, and any change in clinical medication), a scored review at the end, and a written re-plan where the score comes back poor.

That process is genuinely better governance than most of this industry manages, and it is the right thing to ask about. It is still not the same thing as evidence. A catalogue's claim that a protocol has a marked effect is the house's own assessment of its own work, measured against indicators the house chose, with no control group and no publication. Treat it as a description of how carefully a department works, which is useful, and not as a demonstration that the protocol works, which it cannot be.

What is actually delivered here, and why the cell arm is different

The functional arm the partner hospitals run is the non-cell one: infusion, molecular nutrition, prescription pharmacology where indicated, device therapy, and the follow-up management that carries a guest's year. It needs no disease indication, because it is not a cell product and therefore does not travel on the route that Order 818 governs. That cuts both ways, and the mitochondrial page makes the same point: a protocol with no filing requirement also has none of the filing's scaffolding behind it — no named indication, no approved dose, no protocol on record.

The cell and immune items that appear on the same catalogues are governed differently and are described differently on this site. Licensed cell and gene therapy is presented here as treatment for disease only. It proceeds where the assessment finds a treatable condition, or where a guest arrives holding a diagnosis or prescription from their own physician; it is not sold as a longevity purchase. The rule, its source and what it means in practice are set out once on the legality guide, which is the canonical explanation and the page to read rather than this one. Where a catalogue lists an autologous cell item under an anti-ageing heading, that heading is the catalogue's, not ours.

Who it suits, and who should not bother

It suits someone whose screening came back with a cluster rather than a diagnosis — drifting metabolic markers, a raised inflammatory or homocysteine picture, poor micronutrient status, a gut or liver problem that has not yet become a disease — and who wants that cluster worked on as one object by a team that holds the whole file. It suits someone who will actually do the three-month oral and lifestyle half, because on this model the infusion is the fast adjustment and the slow work is where any durable change would have to come from. It pairs naturally with the year of follow-up described in what happens on a longevity retreat.

It is not for someone whose panel is clean and who wants a drip anyway; on the model's own logic there is nothing at stage three to adjust, and on the evidence there is nothing to gain. It is not for someone with an established disease who is hoping to avoid its treatment — that is the failure mode this whole category is notorious for, and the fifth row of the table above is where such a guest belongs. It is not a substitute for the boring interventions that actually move mortality. And anyone who wants a single procedure with a single named outcome will find a functional programme frustrating by design, because it is a year of adjustments, not an event.

What it costs

We do not publish a price list for the treatment programmes, and the functional arm is not one of the three regenerative programmes included in the four-day retreat, which is offered from about $2,700 all-in. What a functional course costs tracks your panel: how many infusion sessions it implies, which oral and device components run alongside, and how long the management period is. For the comparison with Swiss and Alpine longevity clinics, and what the retreat's own figure does and does not cover, the programmes and cost page is the place. Anything beyond the retreat's inclusions is quoted in writing by the hospital that would deliver it, before you commit.

One caution specific to this category, worth more than any price. A functional programme is a long list of separable items, which makes it the easiest thing in medicine to quote as one undifferentiated figure agreed before anyone has read a result. Ask for it the other way round: the results first, then the plan, then a written quote from the hospital that would deliver it, item by item.

Seven questions to ask any functional medicine clinic

Frequently asked

What is functional medicine?

Functional medicine is a way of organising care around mechanism rather than diagnosis. Conventional clinical medicine names a disease and treats it; functional medicine asks which upstream systems — digestion and the gut barrier, liver clearance, micronutrient status, inflammatory load, metabolic and hormonal signalling — are drifting before a disease has a name, and intervenes there. In practice a functional medicine programme is a package: laboratory and functional testing, an intravenous or oral course aimed at a named system, supplements dosed from the panel rather than from a shelf, device-based therapies, and a management year around it. The framing is a genuine clinical philosophy with a real literature behind parts of it. It is also, worldwide, the label most often attached to interventions that have no evidence at all, which is why the useful question is never “is functional medicine real” but “which item in this specific programme has been tested, and in whom”.

Is functional medicine available in China?

Yes, and it is more institutional than the Western version. Several large Chinese private hospital groups run functional medicine as a named department alongside clinical specialties, staffed by licensed physicians and working out of the same hospital that did your screening. The partner hospitals behind a Hainan longevity retreat run their functional arm this way: it sits on the non-cell side of the programme menu with therapeutic plasma exchange, the mitochondrial and NAD+ protocols, hyperbaric oxygen and whole-body immune hyperthermia, and it is the arm that most often carries a guest's follow-up year. Being inside a hospital changes two things that matter: the same team holds your imaging and bloods, and an abnormal result routes into clinical care rather than into another supplement.

What does “1+X” mean in a Chinese functional medicine programme?

It is a house naming convention, not a medical term, and it describes how a programme is assembled. The “1” is the treatment core: functional infusion, molecular nutrients dosed from a panel, conventional pharmaceuticals where they are indicated, and device-based energy therapies. The “X” arms are what can be added around that core — an aesthetic arm, a cell and immune arm, and a mind-body arm running to Ayurvedic oil therapy, meditation and sound work. Read it as a menu structure that tells you where a given item sits and what it is being asked to do. It tells you nothing about the evidence behind any particular line on it, and a programme presented as “1+X” still has to be priced, indicated and consented item by item.

What is functional infusion therapy?

Functional infusion is an intravenous course aimed at a named physiological system rather than at a diagnosed disease — liver clearance, metabolic or mucosal support, micronutrient repletion, mitochondrial substrate. Mechanically it is an ordinary hospital drip: a peripheral line, a bag whose contents are set by the prescribing physician from your panel, one to a few hours in a day-treatment chair, and vitals through the session. A typical course in a partner hospital's own programme document runs a single infusion on each of two consecutive days at around two and a half hours a session, with an oral supplement combination continuing for about three months and device sessions layered on top. What is in the bag is the whole question, and it varies by programme, by physician and by what your results showed.

Is IV vitamin therapy backed by evidence?

Partly, and the honest split matters. Correcting a measured deficiency intravenously is established medicine with unambiguous benefit — iron, B12, vitamin D, magnesium in the right patients. Intravenous repletion where the deficiency has not been measured, or in people whose levels are normal, has no demonstrated benefit on any outcome anybody cares about; the excess is largely excreted. Specific popular items have specific problems: high-dose intravenous vitamin C has failed its randomised sepsis and oncology endpoints, intravenous glutathione has almost no controlled human outcome data, and chelation outside diagnosed heavy-metal toxicity carries real risk without established benefit. So the question to ask of a functional infusion is not what it contains but what measurement led to it, and what will be re-measured afterwards.

Do I need a diagnosis for functional medicine treatment in China?

No. Functional medicine and functional infusion are not cell products, so they do not travel on the route that State Council Order No. 818 governs, and they carry no disease-indication requirement. Licensed cell and gene therapy in the pilot zone is a separate matter: it is delivered for therapeutic purpose only — it proceeds where the assessment finds a treatable condition, or where you arrive holding a diagnosis or prescription from your own physician. You are still screened for the functional arm, results still decide what is prescribed, and the hospital can still decline you on clinical grounds.

How much does functional medicine treatment in China cost?

We do not publish a price list for the treatment programmes, and functional medicine is not one of the three regenerative programmes included in the four-day retreat, which is offered from about $2,700 all-in. A functional course is quoted from what your panel showed, how many infusion sessions it implies, which oral and device components run alongside it and how long the management period is — which is why a figure quoted before anyone has read your results is telling you about the seller rather than the protocol. Anything beyond the retreat's own inclusions is quoted in writing by the hospital that would deliver it, before you commit.

Is functional medicine the same as stem cell therapy?

No, and conflating them is the most common error in this category. Functional medicine is a non-cell discipline: infusions, nutrients, pharmaceuticals and devices, session-based, no manufacturing run, no cell product, no Order 818 file. Cell therapy is a manufactured biological product with a licensed indication, a filed protocol and a hospital-held approval behind it. Some Chinese hospital groups list both on one catalogue and some list them under one heading, which is where the confusion starts. On this site they are kept apart deliberately: the longevity and rejuvenation language belongs to the retreat and to the non-cell programmes, and the cell programmes are described only as treatment for disease.

Or download the Retreat Dossier (PDF) → — itinerary, inclusions, programs, practicalities.